Total Payments
$5,538
2024 Payments
$1,986
Companies
39
Transactions
313
Medicare Patients
1,662
Medicare Billing
$189,063
Payment Breakdown by Category
Food & Beverage$5,533 (99.9%)
Education$5.00 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,533 | 312 | 99.9% |
| Education | $5.00 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,577 | 77 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $744.49 | 39 | $0 (2024) |
| Novo Nordisk Inc | $538.32 | 38 | $0 (2024) |
| Lilly USA, LLC | $489.15 | 25 | $0 (2024) |
| PFIZER INC. | $257.78 | 19 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $168.56 | 11 | $0 (2024) |
| Amgen Inc. | $155.67 | 9 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $141.63 | 7 | $0 (2024) |
| Astellas Pharma US Inc | $122.22 | 7 | $0 (2024) |
| Merck Sharp & Dohme LLC | $113.78 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,986 | 109 | ABBVIE INC. ($485.05) |
| 2023 | $1,351 | 74 | ABBVIE INC. ($480.23) |
| 2022 | $1,398 | 80 | ABBVIE INC. ($548.82) |
| 2021 | $677.77 | 42 | Novo Nordisk Inc ($147.76) |
| 2020 | $124.82 | 8 | Novo Nordisk Inc ($32.50) |
All Payment Transactions
313 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $25.64 | General |
| Category: UROLOGY | ||||||
| 12/04/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $33.79 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/03/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: Obesity | ||||||
| 11/15/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $3.42 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: Respiratory | ||||||
| 11/07/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $12.87 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.12 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: Respiratory | ||||||
| 10/28/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $28.86 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: Hepatitis B Vaccine | ||||||
| 10/16/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $7.89 | General |
| 10/14/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $6.57 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: Diabetes | ||||||
| 10/10/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $10.71 | General |
| Category: PAIN | ||||||
| 10/09/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: Biological | ||||||
| 10/08/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: NEUROSCIENCE | ||||||
| 10/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: Gastroenterology | ||||||
| 10/01/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: Diabetes | ||||||
| 09/24/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $2.32 | General |
| Category: NEUROSCIENCE | ||||||
| 09/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.60 | General |
| Category: NEUROSCIENCE | ||||||
| 09/11/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: Diabetes | ||||||
| 09/05/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), VAXNEUVANCE, CAPVAXIVE | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: VACCINE | ||||||
| 09/04/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: PSYCHIATRY | ||||||
| 09/03/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 463 | 609 | $110,141 | $56,219 |
| 2022 | 10 | 531 | 730 | $114,244 | $57,848 |
| 2021 | 11 | 489 | 690 | $114,002 | $60,829 |
| 2020 | 6 | 179 | 196 | $28,001 | $14,167 |
Total Patients
1,662
Total Services
2,225
Medicare Billing
$189,063
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 170 | 314 | $54,814 | $26,037 | 47.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 127 | 127 | $27,305 | $16,265 | 59.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 24 | 24 | $12,696 | $6,760 | 53.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 26 | 26 | $6,708 | $2,365 | 35.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 24 | 24 | $3,312 | $1,726 | 52.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 21 | 22 | $2,714 | $1,277 | 47.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 30 | 30 | $1,170 | $898.20 | 76.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 24 | 24 | $936.00 | $718.56 | 76.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 17 | 18 | $486.00 | $171.36 | 35.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 170 | 347 | $60,031 | $29,101 | 48.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 133 | 133 | $28,595 | $17,406 | 60.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 49 | 58 | $7,076 | $3,184 | 45.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 35 | 35 | $9,030 | $2,932 | 32.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 33 | 33 | $3,795 | $2,262 | 59.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 48 | 48 | $1,872 | $1,392 | 74.3% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 13 | 15 | $1,920 | $600.77 | 31.3% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 24 | 35 | $945.00 | $335.71 | 35.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 11 | 11 | $429.00 | $319.95 | 74.6% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 15 | 15 | $551.00 | $315.79 | 57.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 159 | 335 | $56,917 | $29,926 | 52.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 89 | 89 | $18,920 | $11,717 | 61.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 66 | 89 | $10,408 | $5,651 | 54.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 47 | 47 | $12,126 | $4,783 | 39.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 23 | 23 | $7,401 | $3,838 | 51.9% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 19 | 19 | $3,040 | $2,374 | 78.1% |
About Dr. Robert Hieger, MD
Dr. Robert Hieger, MD is a Family Medicine healthcare provider based in Festus, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/30/2017. The National Provider Identifier (NPI) number assigned to this provider is 1801328612.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Hieger, MD has received a total of $5,538 in payments from pharmaceutical and medical device companies, with $1,986 received in 2024. These payments were reported across 313 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($5,533).
As a Medicare-enrolled provider, Hieger has provided services to 1,662 Medicare beneficiaries, totaling 2,225 services with total Medicare billing of $189,063. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Festus, MO
- Active Since 03/30/2017
- Last Updated 08/11/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1801328612
Products in Payments
- QULIPTA (Drug) $653.25
- FARXIGA (Drug) $543.24
- UBRELVY (Drug) $505.52
- VRAYLAR (Drug) $392.80
- TRULICITY (Drug) $238.45
- Ozempic (Drug) $204.63
- MOUNJARO (Drug) $197.14
- GEMTESA (Drug) $184.64
- NURTEC ODT (Drug) $170.07
- ELIQUIS (Drug) $145.00
- TRINTELLIX (Drug) $141.63
- Rybelsus (Drug) $117.19
- Veozah (Drug) $105.36
- XIFAXAN (Drug) $101.65
- AIRSUPRA (Drug) $98.61
- Otezla (Drug) $97.51
- Wegovy (Drug) $93.07
- Cologuard Collection Kit (Device) $89.62
- JARDIANCE (Drug) $85.03
- Vascepa (Drug) $84.09
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Festus
Dr. Leah Silver, D.o, D.O
Family Medicine — Payments: $39,256
Family Medicine $39,256
Dr. Kenneth Kilian, M.d, M.D
Family Medicine — Payments: $10,454
Family Medicine $10,454
Dr. Laurie Womack, M.d, M.D
Family Medicine — Payments: $6,300
Family Medicine $6,300
Lawrence Rudolf, Md, MD
Family Medicine — Payments: $4,895
Family Medicine $4,895
Emily Bhandare, Md, MD
Family Medicine — Payments: $4,632
Family Medicine $4,632
Mr. Gary Sides, D.o, D.O
Family Medicine — Payments: $3,539
Family Medicine $3,539